ENZYMERX
EnzymeRx! a private, clinical stage biotechnology company developing uricase-PEG 20 for the treatment of resistant and refractory gout and related indications in which hyperuricemia plays a causative role. Our patented formulation of pegylated uricase is designed to have a long half life as well as reduced immunogenicity.
ENZYMERX
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2008-01-01
Address:
Paramus, New Jersey, United States
Country:
United States
Website Url:
http://www.enzymerx.com
Total Employee:
1+
Status:
Active
Contact:
201-843-4424
Email Addresses:
[email protected]
Total Funding:
14 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving Mobile Non Scaleable Content Nginx Baidu Analytics AliDNS
Similar Organizations
Cocrystal Discovery
Cocrystal Discovery is a biotechnology company developing antiviral therapeutics for human diseases.
EnClear Therapies
EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease
Toltec Pharmaceuticals
Toltec Pharmaceuticals is a biotechnology company developing therapeutics for the treatment of lower reproductive tract infection.
Current Employees Featured
Investors List
Pequot Capital
Pequot Capital investment in Venture Round - EnzymeRx
Official Site Inspections
http://www.enzymerx.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
